Diametric Capital’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$562K Buy
+76,957
New +$725K 0.05% 338

Other funds holding PHAT

Diametric Capital's PHAT Position: Q3 2026 in Review

Diametric Capital opened a new position in Phathom Pharmaceuticals (PHAT) in Q3 2026: 76,957 shares worth $562K. The stake represents 0.05% of the portfolio and ranks #338 among its holdings.

161 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.

  • Diametric Capital held 76,957 shares of Phathom Pharmaceuticals worth $562K as of Q3 2026.
  • Phathom Pharmaceuticals was a new Diametric Capital position in Q3 2026.
  • Phathom Pharmaceuticals made up 0.05% of Diametric Capital's portfolio in Q3 2026, its #338 holding.
  • 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.

Based on Diametric Capital's 13F filing for Q3 2026, filed 16 Nov 2026.